2.5 Parallel session: Improving the treatment and management of tuberculosis

Presentations:

**OA-424 - Evaluating lineage-specific response to tuberculosis treatment regimens using clinical Mycobacterium tuberculosis complex isolates
**Fatou Faal, Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, The Gambia

**OA-463 - Proportions, patterns and hotspots of group a drug-resistant tuberculosis in the Western Cape: insights from routinely collected laboratory data
**Erick Auma, Stellenbosch University, South Africa

**OA-230 - Pharmacokinetic considerations in managing tuberculosis in patients with type-2 diabetes mellitus
**Augustine Boadu Asare, University of Ghana, Ghana

**OA-535 - Association of human Cytomegalovirus exposure with tuberculosis disease in TB presumptive South African adults
**Derrick Semugenze, Makerere University and University of Amsterdam, Uganda

**OA-724 - Pilot phase 2b N-Acetylcysteine trial: a promising solution for protecting kidney and liver health in drug-resistant tuberculosis treatment
**Stellah Mpagama, Kibong'oto Infectious Diseases Hospital, Tanzania